Brief: Ark Investment Management LLC Reports 10.75% Passive Stake In CRISPR Therapeutics As Of Dec 31, 2023 Versus 10.16% As Of March 31, 2023 - SEC Filing
Jan 10 (Reuters) - Ark Investment Management LLC:
* ARK INVESTMENT MANAGEMENT LLC REPORTS 10.75% PASSIVE STAKE
IN
CRISPR THERAPEUTICS AS OF DEC 31, 2023 VERSUS 10.16% AS OF MARCH
31, 2023 - SEC FILING
Further company coverage: CRSP.BN
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crispr Therapeutics AG
See all newsBrief: CRISPR Therapeutics Announces Chief Financial Officer Transition
Swiss stocks - Factors to watch on August 4
Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansion
Swiss stocks - Factors to watch on August 3
Gene-editing firm CRISPR steadies after boosted $550 mln convertible debt deal